ArticleBMC cancer2025

In vivo inhibition of c-MYC in the metastatic drug-resistant ovarian cancer cells down regulates the c-MYC-PD-L1-PAX8-p21 to achieve therapeutic efficacy.

Queenie Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.